MULTIFACTORIAL ANALYSIS OF THE DEPENDENCE OF PRESCRIBED DIAGNOSTIC TEST SYSTEMS AND PURCHASED TARGETED DRUGS ON THE EXAMPLE OF LUNG ADENOCARCINOMA IN ST. P

Based on the results of the analysis, it was concluded that the currently existing system of drug provision for oncological patients requires the creation of unified mechanisms that allow for the reasonable purchase of targeted drugs by increasing molecular genetic testing in medical institutions, as well as rational use of state budget funds. As part of the state registration procedure and on the basis of clinical and economic analysis, it is necessary to determine the types of necessary new medical technologies, providing appropriate amounts in the budgets of the program of state guarantees and preferential drug provision for the population, with justification for calculating tariffs.